ym155
Showing 1 - 10 of 10
NSCLC, Solid Tumors Trial run by the NCI (YM155, Carboplatin, Paclitaxel)
Completed
- NSCLC
- Solid Tumors
- YM155
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Sep 29, 2015
Prostate Cancer, Melanoma, Non-Hodgkin's Lymphoma Trial in San Antonio, Salt Lake City (YM155)
Completed
- Prostate Cancer
- +2 more
- YM155
-
San Antonio, Texas
- +2 more
Aug 20, 2015
Lymphoma, Large-Cell, Diffuse, Lymphoma, B-Cell Refractory Trial in Worldwide (YM155)
Terminated
- Lymphoma, Large-Cell, Diffuse
- Lymphoma, B-Cell Refractory
- YM155
-
Beverly Hills, California
- +21 more
Aug 20, 2015
Non-Hodgkin's Lymphoma Trial in Worldwide (YM155, Rituximab)
Completed
- Non-Hodgkin's Lymphoma
- YM155
- Rituximab
-
Columbus, Georgia
- +18 more
Sep 29, 2015
Melanoma Trial in United States (YM155)
Completed
- Melanoma
- YM155
-
Tuscon, Arizona
- +8 more
Jun 6, 2012
Prostate Cancer, Cancer of Prostate, Prostatic Cancer Trial in Netherlands, United Kingdom, United States (YM155)
Completed
- Prostate Cancer
- +3 more
- YM155
-
Tuscon, Arizona
- +8 more
Jun 6, 2012
Cancer Trial in Budapest (YM155)
Completed
- Cancer
- YM155
-
Budapest, Hungary(unnamed)
Apr 12, 2010
Lung Cancer, Cancer of Lung, Cancer of the Lung Trial in Czech Republic, Germany, Netherlands (YM155)
Completed
- Lung Cancer
- +4 more
- YM155
-
Chomutov, Czech Republic
- +7 more
Dec 26, 2007